Corporate VC · Ingelheim (Germany), Cambridge (United States), Beijing (China), Boston (United States), San Francisco (United States), Hong Kong (China), Shanghai (China) · Founded 2010
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science with the potential for significant patient benefit, focusing on areas like immunology, regenerative medicine, and digital health. The fund provides financial support and strategic guidance to portfolio companies.
Seed, Series A, Series B
BioTech, Digital Health, New Therapeutic Modalities, Patients Care Management, Pharma, Tissue Regeneration
Unlock for 1 credit to view portfolio companies and the full investment list.
Unlock for 1 credit to view team members and contact details.
Unlock for 1 credit to view website, LinkedIn, and other firm links.